Poonam Beniwal-Patel MD
Associate Professor
Institution: Medical College of Wisconsin
Department: Medicine
Division: Gastroenterology
Program: Administration
Send Message
Request Meeting
Clinical Expertise
Colitis, UlcerativeCrohn DiseaseInflammatory Bowel DiseasesPublications (34)
Risankizumab Is Effective for The Management of Crohn's Disease of the Pouch. (Kayal M, Spencer EA, Smyth M, Raffals L, Qazi T, Deepak P, Beniwal-Patel P, Chang S, Higgins P, Cross RK, Anderson C, Long M, Herfarth HH, Dubinsky MC, Barnes EL) Inflamm Bowel Dis 2024 Jul 22 PMID: 39038228 07/22/2024 Surgery for Crohn's Disease Is Associated With a Dysbiotic Microbiome and Metabolome: Results From Two Prospective Cohorts. (Lewis JD, Daniel SG, Li H, Hao F, Patterson AD, Hecht AL, Brensinger CM, Wu GD, Bittinger K, DINE-CD, SPARC IBD Investigators) Cell Mol Gastroenterol Hepatol 2024;18(3):101357 PMID: 38750900 PMCID: PMC11278594 SCOPUS ID: 2-s2.0-85197576208 05/16/2024 2 CitationsPredictive Factors of Non-Inflammatory Small Bowel Obstruction After Bowel Resection in Crohn's Patients. (Zulqarnain M, Jaber F, Jahagirdar V, Alsakarneh S, Gomez J, Stanton A, Patel N, Beniwal-Patel P, Stein D, Otterson M, Yarur AJ) Gastroenterology Res 2024 Apr;17(2):64-71 PMID: 38716284 PMCID: PMC11073459 SCOPUS ID: 2-s2.0-85193272140 05/08/2024 Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort Consortium. (Yarur AJ, Ungaro R, Huang K, Wang W, Sasankan P, Zulqarnain M, Johnson AM, Bader G, Kay C, Costable N, Dulaney D, Fenster M, Beniwal-Patel P, Syal G, Patel A, Loftus E Jr, Pekow J, Cohen B, Deepak P) Inflamm Bowel Dis 2025 Jan 06;31(1):131-139 PMID: 38531068 PMCID: PMC11700893 03/26/2024 Structural brain morphometry differences and similarities between young patients with Crohn's disease in remission and healthy young and old controls. (Yeske B, Hou J, Chu DY, Adluru N, Nair VA, Beniwal-Patel P, Saha S, Prabhakaran V) Front Neurosci 2024;18:1210939 PMID: 38356645 PMCID: PMC10864509 SCOPUS ID: 2-s2.0-85184906514 02/15/2024 Racial, Ethnic, and Geographic Disparities in Immunization Rates Among Patients With Inflammatory Bowel Disease. (Beniwal-Patel P, Waclawik G, Browning K, Urmat A, Schell TL, Smith R, Huerta A, Hipp L, Dave S, Shah N, Dillon KE, Reiter-Schreurs K, Russ RK, Mailig MA, Osman F, Farraye FA, Weiss J, Hayney MS, Caldera F) Crohns Colitis 360 2023 Oct;5(4):otad078 PMID: 38130948 PMCID: PMC10734681 SCOPUS ID: 2-s2.0-85184784756 12/22/2023 1 CitationFactors Associated With Extraintestinal Manifestations of Inflammatory Bowel Disease in SPARC-IBD. (Alizadeh M, Motwani K, Siaton BC, Abutaleb A, Ravel J, Cross RK, SPARC-IBD Investigators
) Inflamm Bowel Dis 2024 Nov 04;30(11):2027-2036 PMID: 38102817 PMCID: PMC11532592 SCOPUS ID: 2-s2.0-85201744428 12/16/2023 3 CitationsChanges in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the Pouch. (Kayal M, Deepak P, Beniwal-Patel P, Raffals L, Dubinsky M, Chang S, Higgins PDR, Jiang Y, Cross RK, Long MD, Herfarth HH, Barnes EL) Am J Gastroenterol 2024 Mar 01;119(3):584-587 PMID: 37975591 PMCID: PMC11273367 SCOPUS ID: 2-s2.0-85187115149 11/17/2023 Dietary Patterns Are Not Associated With Disease Activity Among Patients With Inflammatory Conditions of the Pouch in a Prospective Cohort. (Barnes EL, Beniwal-Patel P, Deepak P, Raffals L, Kayal M, Dubinsky M, Chang S, Higgins PDR, Barr JI, Anderson C, Cross RK, Long MD, Herfarth HH) Crohns Colitis 360 2023 Jul;5(3):otad039 PMID: 37519405 PMCID: PMC10374273 SCOPUS ID: 2-s2.0-85168102358 07/31/2023 2 CitationsHigher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study. (Yarur AJ, Bruss A, Moosreiner A, Beniwal-Patel P, Nunez L, Berens B, Colombel JF, Targan SR, Fox C, Melmed GY, Abreu MT, Deepak P) Gastroenterology 2023 Oct;165(4):963-975.e5 PMID: 37499955 PMCID: PMC10589067 SCOPUS ID: 2-s2.0-85168521221 07/28/2023 13 CitationsPatients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission. (Yarur AJ, Abreu MT, Deepak P, Beniwal-Patel P, Papamichael K, Vaughn B, Bruss A, Sekhri S, Moosreiner A, Gu P, Kennedy W, Dubinsky M, Cheifetz A, Melmed GY) Am J Gastroenterol 2023 Nov 01;118(11):2005-2013 PMID: 37207314 PMCID: PMC10720850 SCOPUS ID: 2-s2.0-85175376052 05/19/2023 10 CitationsCombination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab. (Yarur AJ, McGovern D, Abreu MT, Cheifetz A, Papamichail K, Deepak P, Bruss A, Beniwal-Patel P, Dubinsky M, Targan SR, Melmed GY) Clin Gastroenterol Hepatol 2023 Oct;21(11):2908-2917.e10 PMID: 36280102 SCOPUS ID: 2-s2.0-85147031581 10/25/2022 15 CitationsTreatment Patterns and Standardized Outcome Assessments Among Patients With Inflammatory Conditions of the Pouch in a Prospective Multicenter Registry. (Barnes EL, Deepak P, Beniwal-Patel P, Raffals L, Kayal M, Dubinsky M, Chang S, Higgins PDR, Barr JI, Galanko J, Jiang Y, Cross RK, Long MD, Herfarth HH) Crohns Colitis 360 2022 Jul;4(3):otac030 PMID: 36082341 PMCID: PMC9446900 SCOPUS ID: 2-s2.0-85168138502 09/10/2022 7 CitationsClinical Improvement With Pyridostigmine in a Patient With Acetylcholine Receptor Antibody-Associated Autoimmune Gastrointestinal Dysmotility. (Sekhri S, Massey B, Beniwal-Patel P) ACG Case Rep J 2022 Jun;9(6):e00796 PMID: 35774847 PMCID: PMC9239654 07/02/2022 Ileitis in Adult Multisystem Inflammatory Syndrome: A Case Report (Forson M, Aljadah M, Hammons L, Harrington A, Beniwal-Patel P, Johnson A, Krumpelbeck E, Field J, Strong E, Pearl J, Umpierrez A, Patel JJ) Annals of Internal Medicine Clinical Cases July 2022;1(5) SCOPUS ID: 2-s2.0-85189985278 07/01/2022 Development of the Endoscopic Pouch Score for Assessment of Inflammatory Conditions of the Pouch. (Barnes EL, Long MD, Raffals L, Isaacs K, Stidham RW, Herfarth HH, Contributors) Clin Gastroenterol Hepatol 2023 Jun;21(6):1663-1666.e3 PMID: 35568303 PMCID: PMC9652477 SCOPUS ID: 2-s2.0-85136071112 05/15/2022 8 CitationsOutcomes in patients with inflammatory bowel disease and acute gastrointestinal symptoms who test indeterminate for Clostridioides difficile. (Johnson LK, Munoz-Price S, Patel PB, Patel A, Stein DJ, Yarur AJ) Ann Gastroenterol 2022;35(2):135-139 PMID: 35479586 PMCID: PMC8922265 SCOPUS ID: 2-s2.0-85129263357 04/29/2022 1 CitationSerum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease. (Sekhri S, Rao B, Mohananey A, Beniwal-Patel P, Bruss A, Stein DJ, Yarur AJ) BMJ Open Gastroenterol 2021 Nov;8(1) PMID: 34764142 PMCID: PMC8587383 SCOPUS ID: 2-s2.0-85119838983 11/13/2021 Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium. (Fenster M, Alayo QA, Khatiwada A, Wang W, Dimopoulos C, Gutierrez A, Ciorba MA, Christophi GP, Hirten RP, Ha C, Beniwal-Patel P, Cohen BL, Syal G, Yarur A, Patel A, Colombel JF, Pekow J, Ungaro RC, Rubin DT, Deepak P) Clin Gastroenterol Hepatol 2021 Oct;19(10):2207-2209.e3 PMID: 33068786 PMCID: PMC8044250 SCOPUS ID: 2-s2.0-85100538239 10/18/2020 22 CitationsSafety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis. (Deepak P, Alayo QA, Khatiwada A, Lin B, Fenster M, Dimopoulos C, Bader G, Weisshof R, Jacobs M, Gutierrez A, Ciorba MA, Christophi GP, Patel A, Hirten RP, Colombel JF, Rubin DT, Ha C, Beniwal-Patel P, Ungaro RC, Syal G, Pekow J, Cohen BL, Yarur A) Clin Gastroenterol Hepatol 2021 Aug;19(8):1592-1601.e3 PMID: 32629130 PMCID: PMC7779667 SCOPUS ID: 2-s2.0-85108263030 07/07/2020 75 CitationsAlterations in brain white matter microstructural properties in patients with Crohn's disease in remission. (Hou J, Dodd K, Nair VA, Rajan S, Beniwal-Patel P, Saha S, Prabhakaran V) Sci Rep 2020 Feb 07;10(1):2145 PMID: 32034257 PMCID: PMC7005825 SCOPUS ID: 2-s2.0-85079081056 02/09/2020 17 CitationsCorrection to: Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases. (Yarur AJ, Bruss A, Naik S, Beniwal-Patel P, Fox C, Jain A, Berens B, Patel A, Ungaro R, Bahur B, Dubinsky M, Stein DJ) Dig Dis Sci 2019 Dec;64(12):3674-3675 PMID: 31642007 SCOPUS ID: 2-s2.0-85074053317 10/24/2019 A Verbal Fluency Task-Based Brain Activation fMRI Study in Patients with Crohn's Disease in Remission. (Nair VA, Dodd K, Rajan S, Santhanubosu A, Beniwal-Patel P, Saha S, Prabhakaran V) J Neuroimaging 2019 Sep;29(5):630-639 PMID: 31134699 PMCID: PMC6731164 SCOPUS ID: 2-s2.0-85071740772 05/28/2019 13 CitationsAlterations in resting-state functional connectivity in patients with Crohn's disease in remission. (Hou J, Mohanty R, Nair VA, Dodd K, Beniwal-Patel P, Saha S, Prabhakaran V) Sci Rep 2019 May 15;9(1):7412 PMID: 31092855 PMCID: PMC6520362 SCOPUS ID: 2-s2.0-85065803806 05/17/2019 21 CitationsHigher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel Disease. (Ungaro RC, Yarur A, Jossen J, Phan BL, Chefitz E, Sehgal P, Kamal K, Bruss A, Beniwal-Patel P, Fox C, Patel A, Bahur B, Jain A, Stein D, Naik S, Dubinsky MC) J Crohns Colitis 2019 Aug 14;13(8):963-969 PMID: 31087100 PMCID: PMC7185193 SCOPUS ID: 2-s2.0-85065479019 05/16/2019 53 CitationsVedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases. (Yarur AJ, Bruss A, Naik S, Beniwal-Patel P, Fox C, Jain A, Berens B, Patel A, Ungaro R, Bahur B, Dubinsky M, Stein DJ) Dig Dis Sci 2019 Jun;64(6):1651-1659 PMID: 30835029 PMCID: PMC7057114 SCOPUS ID: 2-s2.0-85062733413 03/06/2019 36 CitationsEfficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort. (Gregory M, Weaver KN, Hoversten P, Hicks SB, Patel D, Ciorba MA, Gutierrez AM, Beniwal-Patel P, Palam S, Syal G, Herfarth HH, Christophi G, Raffals L, Barnes EL, Deepak P) Inflamm Bowel Dis 2019 Aug 20;25(9):1569-1576 PMID: 30810748 PMCID: PMC6939832 SCOPUS ID: 2-s2.0-85071604896 02/28/2019 54 CitationsThe Juncture Between Clostridioides difficile Infection and Inflammatory Bowel Diseases. (Beniwal-Patel P, Stein DJ, Munoz-Price LS) Clin Infect Dis 2019 Jul 02;69(2):366-372 PMID: 30689770 SCOPUS ID: 2-s2.0-85069263875 01/29/2019 6 CitationsUstekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter Cohort. (Weaver KN, Gregory M, Syal G, Hoversten P, Hicks SB, Patel D, Christophi G, Beniwal-Patel P, Isaacs KL, Raffals L, Deepak P, Herfarth HH, Barnes EL) Inflamm Bowel Dis 2019 Mar 14;25(4):767-774 PMID: 30295784 SCOPUS ID: 2-s2.0-85062840933 10/09/2018 68 CitationsStructural Imaging Changes and Behavioral Correlates in Patients with Crohn's Disease in Remission. (Nair VA, Beniwal-Patel P, Mbah I, Young BM, Prabhakaran V, Saha S) Front Hum Neurosci 2016;10:460 PMID: 27695405 PMCID: PMC5025433 SCOPUS ID: 2-s2.0-84988556624 10/04/2016 34 CitationsInfliximab Therapy for Corticosteroid-Resistant Ipilimumab-Induced Colitis. (Beniwal-Patel P, Matkowskyj K, Caldera F) J Gastrointestin Liver Dis 2015 Sep;24(3):274 PMID: 26405697 SCOPUS ID: 2-s2.0-84941091930 09/26/2015 7 CitationsThe role of integrin antagonists in the treatment of inflammatory bowel disease. (Beniwal-Patel P, Saha S) Expert Opin Biol Ther 2014 Dec;14(12):1815-23 PMID: 25288228 SCOPUS ID: 2-s2.0-84910074237 10/08/2014 5 CitationsFeedback to achieve improved sign-out technique. (Doers ME, Beniwal-Patel P, Kuester J, Fletcher KE) Am J Med Qual 2015;30(4):353-8 PMID: 24878514 SCOPUS ID: 2-s2.0-84936768674 06/01/2014 6 CitationsThe status of diagnostic markers for inflammatory bowel disease. (Beniwal P, Harrell L) Curr Gastroenterol Rep 2010 Dec;12(6):479-84 PMID: 20890737 SCOPUS ID: 2-s2.0-78649905095 10/05/2010 16 Citations Last update: 11/11/2024